South America and Asia Pacific to Witness Tremendous Growth in Bioinsecticides Market by 2025

Posted on 2021-09-30 by MarketsandMarkets in Agriculture // 0 Comments

The global bioinsecticides market size is projected to grow at a CAGR of 15.8% from an estimated value of USD 2.2 billion in 2020 to reach USD 4.6 billion by 2025. Factors such as the increasing awareness of consumers about pesticide residues in crops, growing acceptance of organic food, increase in integrated pest management practices, and the ban of pesticides which are detrimental to the public health and environment has led to a huge demand for bioinsecticides, creating sustainable solutions.

Download PDF Brochure

The markets in South America and Asia Pacific to witness tremendous growth during the forecast period.

The increase in agriculture cultivation has led to the use of quality inputs to obtain better crop performance. The need to maintain minimum residual levels in food products and high growth prospects for organic food has been driving the bioinsecticides market in these regions. Stringent regulations in these countries to limit excessive chemical application is also driving the market.

The demand for export-quality fruits and vegetables in Europe and North American region has compelled the farmers to take up sustainable solutions in farming. Even the government has aided through the banning of pesticides so that the adoption of biological solutions grows exponentially. Various key companies are investing in these regions to expand the bioinsecticides business strategically.

Make an Inquiry

The key players in bioinsecticides market include BASF SE (Germany), Bayer AG (Germany), Biobest Group NV (Belgium), Certis USA LLC (US), Novozymes A/S (Denmark), Marrone Bio Innovations (US), Syngenta AG (Switzerland), Nufarm (Australia), Som Phytopharma India Ltd (India) Valent Biosciences LLC (US), BioWorks Inc. (US), Camson Biotechnologies Ltd (India), Andermatt Biocontrol AG (Switzerland), International Panaacea Ltd (India), Kan Biosys (India), Futureco Bioscience S.A. (Spain), KilPest India Ltd (India), BioSafe Systems, LLC. (US), Vestaron Corporation (US), and SDS Biotech K.K (Japan), which contribute significantly.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Matched content

Editor’s pick